User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)

NACompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

September 6, 2018

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Diabetes Mellitus
Interventions
DEVICE

Contour Next and Contour TV3 BGMS testing by subjects with and without Diabetes

Using the first blood glucose monitoring system (BGMS), which is either Contour Next or Contour TV3, subjects perform self fingerstick test and alternative site test on the palm. Staff performs fingerstick test on subject. Using the second BGMS, the palm, self test and staff tests are performed. Subjects with diabetes get a venipuncture and staff tests using both BGMS using the venous blood.

Trial Locations (2)

92025

AMCR Institute, Escondido

98057

Ranier Clinical Research Center, Inc., Renton

Sponsors
All Listed Sponsors
collaborator

Regulatory and Clinical Research Institute Inc

OTHER

lead

Ascensia Diabetes Care

INDUSTRY